We are live on ! Find out more
BMY icon

Bristol-Myers Squibb

2,570 hedge funds and large institutions have $102B invested in Bristol-Myers Squibb in 2026 Q3 according to their latest regulatory filings, with 223 funds opening new positions, 1,034 increasing their positions, 976 reducing their positions, and 136 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 223 | Existing positions closed: 136

6% more repeat investments, than reductions

Existing positions increased: 1,034 | Existing positions reduced: 976

1% more funds holding

Funds holding: 2,549 → 2,570 (+21)

2.5% less ownership

Funds ownership: 82.7% → 80.2% (-2.5%)

5% less funds holding in top 10

Funds holding in top 10: 21 → 20 (-1)

11% less call options, than puts

Call options by funds: $2.1B | Put options by funds: $2.36B

23% less capital inflows, than outflows

Capital inflows: $5.81B | Capital outflows: $7.58B

Holders
2,570
Holders Change
+21
Holders Change %
+0.82%
% of All Funds
31.25%
Holding in Top 10
20
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-4.76%
% of All Funds
0.24%
New
223
Increased
1,034
Reduced
976
Closed
136
Calls
$2.1​B
Puts
$2.36​B
Net Calls
-⁠$259​M
Net Calls Change
-⁠$311​M

BMY Hedge Fund Activity: Q3 2026 in Review

2,570 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2026, worth a combined $102B — up 5% from $97.4B a quarter earlier.

Buyers outnumbered sellers: 223 funds opened new BMY positions and 136 closed out — a net gain of 87 holders — while 1,034 added to existing stakes and 976 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $760M. The largest seller was JP Morgan Chase, cutting an estimated $727M.

  • 2,570 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2026, up from 2,549 in Q2 2026.
  • Funds reported $102B of Bristol-Myers Squibb stock for Q3 2026, up 5% quarter-over-quarter.
  • 223 funds opened new Bristol-Myers Squibb positions in Q3 2026 and 136 closed out, a net change of +87 holders.
  • The largest Bristol-Myers Squibb buyer in Q3 2026 was Fidelity Investments, an estimated $760M added.
  • The largest Bristol-Myers Squibb seller in Q3 2026 was JP Morgan Chase, an estimated $727M sold.

Based on aggregated 13F filings for Q3 2026.